CLINICAL_TRIALS
trial_result
· 2026-01-21
Clinical Trial Update: EndoForce Post Approval Study
Summary
A post-approval study for EndoForce is currently recruiting participants with end-stage renal disease (ESRD).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Phraxis, Inc. | Conditions: End Stage Renal Disease (ESRD) | Status: RECRUITING